Librela is a revolutionary treatment that uses monoclonal antibodies (MAB) to target Nerve Growth Factor (NGF) - a significant player in dog and cat arthritic pain.  It is a once a month injection for dogs that is done in the veterinary office. Librela has shown great success in helping to manage pain associated with osteoarthritis.